You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

 

Online download statistics by month:

Online download statistics by month: August 2022 to September 2025

AbstractFullPdf
Aug 2022640653154
Sep 2022621629135
Oct 202237138280
Nov 202213113646
Dec 202212012121
Jan 202310010113
Feb 2023737419
Mar 2023636412
Apr 2023676825
May 2023727220
Jun 2023818218
Jul 202334359
Aug 2023505122
Sep 2023383916
Oct 2023323226
Nov 2023454512
Dec 2023444414
Jan 2024293010
Feb 2024535523
Mar 2024232323
Apr 2024292928
May 2024212314
Jun 2024313020
Jul 2024484923
Aug 202429289
Sep 2024474720
Oct 2024515123
Nov 2024373812
Dec 2024606423
Jan 2025444521
Feb 20251201212
Mar 2025454522
Apr 2025666619
May 2025495324
Jun 2025212420
Jul 2025110
Sep 2025110
Total33873451978